S, A., K, A., C, L., R, R., V, M., P, H., . . . RK, R. Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study. Dove Medical Press.
Chicago Style (17th ed.) CitationS, Ancona, et al. Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study. Dove Medical Press.
MLA (9th ed.) CitationS, Ancona, et al. Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study. Dove Medical Press.
Warning: These citations may not always be 100% accurate.